The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALEXION PHARMACEUTICALS INC COM 015351109 10,233 56,610 SH   SOLE   56,610 0 0
AMGEN INC COM 031162100 14,835 96,630 SH   SOLE   96,630 0 0
AXOVANT SCIENCES LTD COM G0750W104 14,123 692,961 SH   SOLE   692,961 0 0
BELLICUM PHARMACEUTICALS INC COM 079481107 1,463 68,780 SH   SOLE   68,780 0 0
HEWLETT PACKARD CO COM 428236103 10,113 337,000 SH   SOLE   337,000 0 0
HORNBECK OFFSHORE SVCS INC N COM 440543106 7,241 352,720 SH   SOLE   352,720 0 0
INFOBLOX INC COM 45672H104 6,051 230,872 SH   SOLE   230,872 0 0
KITE PHARMA INC COM 49803L109 6,432 105,498 SH   SOLE   105,498 0 0
NIVALIS THERAPEUTICS INC COM 65481J109 3,409 225,000 SH   SOLE   225,000 0 0
OCULAR THERAPEUTIX INC COM 67576A100 14,964 711,533 SH   SOLE   711,533 0 0
VIOLIN MEMORY INC COM 92763A101 9,640 3,934,580 SH   SOLE   3,934,580 0 0